These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1711366)

  • 1. Bladder cancer chemotherapy: is response of squamous tumours different to that of transitional cell tumours?
    Oliver RT
    Ann Oncol; 1991 Feb; 2(2):87-8. PubMed ID: 1711366
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for advanced urothelial cancer.
    Yagoda A
    Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer.
    Hickey DP; Brausi M; Blatnik AF; Soloway MS
    Urology; 1987 Nov; 30(5):484-7. PubMed ID: 3118551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for invasive bladder carcinoma.
    Fair WR
    Mayo Clin Proc; 1988 Jan; 63(1):86-7. PubMed ID: 3275847
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy and bladder cancer.
    Garnick MB
    J Urol; 1989 Jan; 141(1):107. PubMed ID: 2642307
    [No Abstract]   [Full Text] [Related]  

  • 6. Histopathologic changes of transitional cell carcinoma of bladder after M-VAC chemotherapy.
    Javadpour N; Daloni P
    Urology; 1989 Dec; 34(6):357-9. PubMed ID: 2595881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic management of invasive bladder carcinoma.
    Sternberg CN; Yagoda A; Scher HI; Watson RC; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N; Geller N
    Eur Urol; 1988; 14 Suppl 1():19-20. PubMed ID: 3053199
    [No Abstract]   [Full Text] [Related]  

  • 8. Analyses of factors affecting the outcome of combination chemotherapy in patients with advanced bladder cancer.
    Igawa M; Ohkuchi T; Ueda M; Usui T; Kawanishi M
    Eur Urol; 1991; 20(1):12-5. PubMed ID: 1743224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of M-VAC combination chemotherapy in the treatment of patients with invasive and metastatic bladder cancer.
    Soloway MS
    Eur Urol; 1988; 14 Suppl 1():42. PubMed ID: 3181242
    [No Abstract]   [Full Text] [Related]  

  • 10. M-VAC chemotherapy in the management of locally advanced bladder cancer.
    Skinner DG
    J Urol; 1988 Mar; 139(3):570. PubMed ID: 3343745
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
    Fair WR; Scher H; Herr H; Morse M; Sogani P; Bosi G; Dershaw D; Reuter V; Curley T
    Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
    [No Abstract]   [Full Text] [Related]  

  • 12. MVAC for bladder cancer: time to move forward again.
    Levine EG; Raghavan D
    J Clin Oncol; 1993 Mar; 11(3):387-9. PubMed ID: 8445412
    [No Abstract]   [Full Text] [Related]  

  • 13. Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
    Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bosl G; Watson RC; Hollander PS
    Prog Clin Biol Res; 1988; 260():551-5. PubMed ID: 3283770
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible alternative treatment for advanced transitional cell carcinoma of the urothelium (N+ and/or M+) in 1988.
    Perrin P; Mouriquand P; Monsallier M; Devonec M
    Prog Clin Biol Res; 1989; 303():617-9. PubMed ID: 2780666
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
    [No Abstract]   [Full Text] [Related]  

  • 16. Bladder-sparing approach in the treatment of invasive bladder cancer.
    Wajsman Z; Marino R; Parsons J; Oblon D; McCarley D
    Semin Urol; 1990 Aug; 8(3):210-5. PubMed ID: 2119051
    [No Abstract]   [Full Text] [Related]  

  • 17. M-VAC or MVC for the treatment of advanced transitional cell carcinoma: metastatic, induction, and adjuvant.
    Soloway MS; Ishikawa S; Taylor T; Ezell G
    J Surg Oncol Suppl; 1989; 1():40-5. PubMed ID: 2765094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local response and long-term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladder.
    Abi-Aad AS; Stenzl A; Figlin R; deKernion JB
    Eur J Cancer; 1993; 29A(8):1223-4. PubMed ID: 8518043
    [No Abstract]   [Full Text] [Related]  

  • 19. Second-line chemotherapy in advanced bladder cancer.
    Pavone-Macaluso M; Sternberg C
    Urol Int; 2000; 64(2):61-9. PubMed ID: 10810266
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.